Pictet Asset Management
IMGN

Pictet Asset Management’s Immunogen Inc IMGN Stock Holding History

Pictet Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-975,962
Closed -$28.9M – 2042
2023
Q4 		$28.9M Sell
975,962
-2,732,177
-74% -$54.4M 0.03% 391
2023
Q3 		$58.8M Buy
+3,708,139
New +$61.7M 0.07% 268

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management's IMGN Position: Q1 2024 in Review

Pictet Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 975,962 shares — an estimated $28.9M sold.

Pictet Asset Management first reported a position in IMGN in Q3 2023 and held it in 2 quarters. The position peaked at $58.8M in Q3 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Pictet Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 975,962 Immunogen Inc shares in Q1 2024, an estimated $28.9M.
  • Pictet Asset Management first reported a position in Immunogen Inc in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Immunogen Inc position peaked at $58.8M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.